

LecTec Corporation Announces Four Directors Not Standing For Re-election
TEXARKANA, Texas--([ BUSINESS WIRE ])--LecTec Corporation (OTCBB: LECT) announced today that Judd Berlin, Andy Rollwagen, Dr. Daniel Sigg and Ramanathan Periakaruppan will not be standing for reelection to the Board of Directors at the September 22, 2010, Annual Shareholders Meeting. The Proxy Statement for the Annual Meeting, which will include information concerning the slate of directors to be recommended by the Board, is expected to be mailed around August 20, 2010.
"I appreciate the dedication and long time service of those Board members who will be stepping down at the Annual Shareholders Meeting."
Greg Freitag, LecTec CEO, commented aI appreciate the dedication and long time service of those Board members who will be stepping down at the Annual Shareholders Meeting.a
About LecTec
LecTec is an intellectual property (aIPa) licensing and holding company with approximately $10,000,000 in cash at March 31, 2010. LecTec holds multiple domestic and international patents based on its original hydrogel patch technology and has also filed for a provisional patent forits hand sanitizer patch. The LecTec hydrogel patch technology allows for a number of potential applications, including its previously marketed TheraPatch® products, while its anti-micorbial hand sanitizer patch is intended to be dry, thereby rendering the patch harmless in the event that it is licked, chewed, or exposed to the eye. An initial prototype of the LecTec hand sanitizer patch has been developed. Although LecTec is conducting limited research and development on its hand sanitizer patch, it intends to engage a strategic partner to complete the hand sanitizer patch development and bring it to market. LecTec also has a licensing agreement (aNovartis Agreementa or aAgreementa) with Novartis Consumer Health, Inc. (aNovartisa), which pays royalties to LecTec from time to time, within the terms of the Agreement, based upon a percentage of Novartisa™ net sales of licensed products. LecTec takes legal action as necessary to protect its IP and is currently involved in two patent infringement actions. Finally, LecTec is pursuing a merger/acquisition strategy with the intent to leverage its cash asset and improve shareholder value and liquidity. The Companya™s website is [ www.lectec.com ].
Cautionary Statements
This press release contains forwarda"looking statements concerning possible or anticipated future results of operations or business developments which are typically preceded by the words abelieves,a awants,a aexpects,a aanticipates,a aintends,a awill,a amay,a ashould,a or similar expressions. Such forward-looking statements are subject to risks and uncertainties, which could cause results or developments to differ materially from those, indicated in the forwarda"looking statements. Such risks and uncertainties include, but are not limited to, the Companya™s dependence on royalty payments from Novartis Consumer Health, Inc., which is selling an adult vapor patch licensed by the Company, the Companya™s dependence on key personnel and Board of Director members, the Companya™s pending patent infringement litigation against Chattem, Inc. and Prince of Peace Enterprises, Inc., the issuance of new accounting pronouncements, information disseminated on internet message boards from posters expressing opinions that may or may not be factual, the availability of opportunities for license, sale or strategic partner agreements related to patents that the Company holds, limitations on market expansion opportunities, and other risks and uncertainties detailed from time to time in the Companya™s filings with the Securities and Exchange Commission, and particularly as described in the aRisk Factorsa included in our Form 10a"K for the year ended December 31, 2009.